Remove Compliance Remove Engineering Remove Protein Expression
article thumbnail

Finding the right CDMO partner for cell line development

Drug Target Review

Together, these attributes provide a strong foundation for protein expression with enough adaptability to produce much of the commercial and therapeutic protein market. Finding the right CDMO may require significant time and company resources, but CLD sits at the heart of biologics development.

article thumbnail

Driving efficiency across upstream bioprocess workflow

Drug Target Review

Advancements in genetic and protein engineering through technology innovation, automation, and more recently machine learning, have led to the development of more complex molecules such as bispecific antibodies and antibody drug conjugates. References Mistry RK, Kelsall E, Sou SN, et al. Budge JD, Knight TJ, Povey J, et al.

article thumbnail

mRNA Cancer Vaccines and Therapies: An Overview

Advarra

One strategy proposed the use of synthetic mRNA or modified mRNA analogs, which can enhance the stability and protein expression of mRNA. Monoclonal Antibodies Monoclonal antibodies are lab-engineered immune system proteins. The post mRNA Cancer Vaccines and Therapies: An Overview appeared first on Advarra.

Vaccine 52